332 related articles for article (PubMed ID: 26307759)
1. Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review.
LaFountaine JS; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):43-55. PubMed ID: 26307759
[TBL] [Abstract][Full Text] [Related]
2. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
3. Enabling thermal processing of ritonavir-polyvinyl alcohol amorphous solid dispersions by KinetiSol® Dispersing.
LaFountaine JS; Jermain SV; Prasad LK; Brough C; Miller DA; Lubda D; McGinity JW; Williams RO
Eur J Pharm Biopharm; 2016 Apr; 101():72-81. PubMed ID: 26861929
[TBL] [Abstract][Full Text] [Related]
4. Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol dispersing.
Dinunzio JC; Brough C; Hughey JR; Miller DA; Williams RO; McGinity JW
Eur J Pharm Biopharm; 2010 Feb; 74(2):340-51. PubMed ID: 19818402
[TBL] [Abstract][Full Text] [Related]
5. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol®: a Review.
Ellenberger DJ; Miller DA; Williams RO
AAPS PharmSciTech; 2018 Jul; 19(5):1933-1956. PubMed ID: 29846889
[TBL] [Abstract][Full Text] [Related]
6. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer-surfactant combinations using solubility parameters and testing the processability.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Int J Pharm; 2007 Jan; 328(2):119-29. PubMed ID: 16968659
[TBL] [Abstract][Full Text] [Related]
7. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
Ghebremeskel AN; Vemavarapu C; Lodaya M
Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
[TBL] [Abstract][Full Text] [Related]
8. Innovations in Thermal Processing: Hot-Melt Extrusion and KinetiSol® Dispersing.
Tan DK; Davis DA; Miller DA; Williams RO; Nokhodchi A
AAPS PharmSciTech; 2020 Nov; 21(8):312. PubMed ID: 33161479
[TBL] [Abstract][Full Text] [Related]
9. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
10. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions.
LaFountaine JS; Prasad LK; Brough C; Miller DA; McGinity JW; Williams RO
AAPS PharmSciTech; 2016 Feb; 17(1):120-32. PubMed ID: 26729526
[TBL] [Abstract][Full Text] [Related]
11. Homogeneity of amorphous solid dispersions - an example with KinetiSol
Jermain SV; Miller D; Spangenberg A; Lu X; Moon C; Su Y; Williams RO
Drug Dev Ind Pharm; 2019 May; 45(5):724-735. PubMed ID: 30653376
[TBL] [Abstract][Full Text] [Related]
12. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
13. The utilization of drug-polymer interactions for improving the chemical stability of hot-melt extruded solid dispersions.
Guo Z; Lu M; Li Y; Pang H; Lin L; Liu X; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):285-96. PubMed ID: 24433427
[TBL] [Abstract][Full Text] [Related]
14. Recent studies on the processes and formulation impacts in the development of solid dispersions by hot-melt extrusion.
Tran PHL; Lee BJ; Tran TTD
Eur J Pharm Biopharm; 2021 Jul; 164():13-19. PubMed ID: 33887388
[TBL] [Abstract][Full Text] [Related]
15. Interactions between drugs and polymers influencing hot melt extrusion.
Li Y; Pang H; Guo Z; Lin L; Dong Y; Li G; Lu M; Wu C
J Pharm Pharmacol; 2014 Feb; 66(2):148-66. PubMed ID: 24325738
[TBL] [Abstract][Full Text] [Related]
16. A combined mathematical model linking the formation of amorphous solid dispersions with hot-melt-extrusion process parameters.
Schittny A; Ogawa H; Huwyler J; Puchkov M
Eur J Pharm Biopharm; 2018 Nov; 132():127-145. PubMed ID: 30240820
[TBL] [Abstract][Full Text] [Related]
17. Multiple Linear Regression Modeling To Predict the Stability of Polymer-Drug Solid Dispersions: Comparison of the Effects of Polymers and Manufacturing Methods on Solid Dispersion Stability.
Fridgeirsdottir GA; Harris RJ; Dryden IL; Fischer PM; Roberts CJ
Mol Pharm; 2018 May; 15(5):1826-1841. PubMed ID: 29533634
[TBL] [Abstract][Full Text] [Related]
18.
Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
[TBL] [Abstract][Full Text] [Related]
19. The application of temperature-composition phase diagrams for hot melt extrusion processing of amorphous solid dispersions to prevent residual crystallinity.
Moseson DE; Taylor LS
Int J Pharm; 2018 Dec; 553(1-2):454-466. PubMed ID: 30393199
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the interactions of enteric and hydrophilic polymers to enhance dissolution of griseofulvin following hot melt extrusion processing.
Bennett RC; Keen JM; Bi YV; Porter S; Dürig T; McGinity JW
J Pharm Pharmacol; 2015 Jul; 67(7):918-38. PubMed ID: 25645386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
